Andrew Hertler, MD, FACP

home / authors / andrew-hertler-md-facp

Articles

Ander Hertler, MD | Image credit: Evolent

February 19th 2025

Clinical Trials Must Represent Those Who Will Receive Therapy

Andrew Hertler, MD, FACP

CAR T-cell therapy | Image credit: Getty Images Science Library

June 12th 2024

Whither CAR T? Will the FDA Being Under the Hood and the Availability of Bispecifics Make These Therapies Less Attractive?

Sang Chau, PharmD, BCOP Justin Tse, PharmD, BCOP Amy VanGalder, PharmD, BCOP Garrick Wong, PharmD Terra Wonsettler, PharmD, MBA Andrew Hertler, MD, FACP

February 14th 2024

Genetic Testing in Cancer Care: Considerations for a Condition-Based Approach

Andrew Hertler, MD, FACP Sadie Dobrozsi, MD, MS

Latest Updated Articles

Hands holding pack of cigarettes | Image credit: Nopphon – stock.adobe.com

Published: January 16th 2025 | Updated: January 29th 2025

FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions